AVYA yields 726.48% · JNJ yields 2.14%● Live data
📍 AVYA pulled ahead of the other in Year 1
Combined, AVYA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AVYA + JNJ for your $10,000?
Avaya Holdings Corp., through its subsidiaries, provides digital communications products, solutions, and services for businesses worldwide. The company operates in two segments, Products & Solutions and Services. The Products & Solutions segment offers unified communications and collaboration (UCC), and contact center (CC) platforms, applications, and devices. It also provides Avaya OneCloud UCaaS solutions that enables organizations to provide their workers with a single application for all-channel calling, messaging, meetings, and team collaboration with the same use as existing consumer apps; and Avaya OneCloud CCaaS solutions, which enables customers to build a customized portfolio of applications driving customer engagement and customer value, as well as offers communications solutions include voice, email, chat, social media, video, performance management, and third-party integration. This segments Avaya OneCloud CPaaS solutions combines the cloud with its communications platforms, which enables developers to integrate both UCC and CC communications capabilities directly into internal and customer-facing applications and workflows. The Services segment provides global support services, enterprise cloud and managed services, and professional services. The company also offers business devices, such as IP-enabled handsets, multimedia devices, and conferencing systems. It sells directly through its sales force, as well as indirectly through its network of channel partners, including distributors, service providers, dealers, value-added resellers, system integrators, and business partners. The company has a strategic collaboration with RingCentral, Inc. to accelerate the company's transition to the cloud. Avaya Holdings Corp. is headquartered in Durham, North Carolina.
Full AVYA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.